GSK plc
GLAXF
$20.00
$0.653.36%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -46.81% | -57.52% | -72.22% | -67.46% | -65.88% |
| Total Depreciation and Amortization | 15.38% | 95.62% | 33.86% | -4.89% | 6.90% |
| Total Amortization of Deferred Charges | 7.16% | 5.24% | 5.24% | 5.24% | 5.24% |
| Total Other Non-Cash Items | 203.35% | -122.26% | 100.00% | 103.62% | 105.07% |
| Change in Net Operating Assets | 137.46% | 169.89% | 126.85% | 120.78% | 38.37% |
| Cash from Operations | -0.79% | 39.38% | 70.93% | 62.75% | -8.51% |
| Capital Expenditure | -9.37% | -9.67% | -12.47% | -17.50% | -17.25% |
| Sale of Property, Plant, and Equipment | 138.58% | -92.44% | -85.05% | -84.02% | -79.78% |
| Cash Acquisitions | 43.12% | 50.10% | 80.83% | 26.13% | 51.10% |
| Divestitures | -137.24% | -159.93% | -165.56% | 208.37% | 219.78% |
| Other Investing Activities | -15.45% | 853.91% | 805.89% | 264.94% | 123.40% |
| Cash from Investing | 19.54% | 105.55% | 106.90% | 74.61% | 81.84% |
| Total Debt Issued | 501.35% | -149.18% | -147.15% | -112.66% | -89.10% |
| Total Debt Repaid | 2.04% | 2.67% | 37.67% | 55.94% | 59.39% |
| Issuance of Common Stock | 66.67% | 90.91% | 5.26% | -4.35% | -62.50% |
| Repurchase of Common Stock | -- | -- | -- | -- | 71.43% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -11.75% | -6.56% | 0.10% | 23.73% | 35.44% |
| Other Financing Activities | -8.72% | 18.46% | -311.76% | -226.95% | -109.21% |
| Cash from Financing | 14.29% | -126.95% | -188.37% | 12.65% | -464.85% |
| Foreign Exchange rate Adjustments | 43.11% | -366.91% | -69.62% | -181.81% | -165.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 202.46% | 104.40% | 96.15% | 98.26% | -264.83% |
